Read more
XTB Online Trading

Moderna’s stocks surge in pre-market on vaccine hopes. Dow futures up 500 points

1:02 PM 18 May 2020
Moderna’s (MRNA.US)  announced that its experimental vaccine for coronavirus showed promise in early trials. Biotech company announced that it's  early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all 45 participants.  Vaccine also kept the virus that causes Covid-19 from replicating in the lungs of mice. Moderna has developed the first experimental coronavirus medicine, but an approved treatment is more than a year away.
Moderna’s (MRNA.US) stock rocketed over 28% in pre market trading. Source: xStation5
S&P500 (US500) -  Futures contracts tied to the major U.S. stock indexes rose sharply Monday, as news from a Moderna trial stoked optimism about a potential coronavirus vaccine. Source: xStation5
Share:
Back

Market News

02.05.2025
18:50

Daily summary: Market euphoria, US100 returns above 20,000 points 📈

Wall Street ends the week with strong gains after solid NFP data and news of potential trade talks between China and the USA (S&P 500: +1.4%,...

 17:21

Indices extend gains after Beijing’s potential offer to cooperate with the U.S. on fentanyl 💰📄

Beijing is considering offering cooperation on controlling fentanyl-related chemicals as a way to ease tensions with the U.S. and restart trade talks,...

 15:17

US Open: Strong labor market supports equities performance 📈

Indices on Wall Street are opening on an enthusiastic note, recording gains of 1.30–1.60%. This time, the upward impulse came from strong labor market...
More news

Join over 1 400 000 XTB Group Clients from around the world

Start trading Download the app Download the app
The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits